These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36083488)

  • 1. Wenshen Jianpi recipe induced immune reconstruction and redistribution of natural killer cell subsets in immunological non-responders of human immunodeficiency virus/acquired immune deficiency syndrome: a randomized controlled trial.
    Zhuang T; Jian W; Xin C; Yonghong LI; Yuguang Y; Ao Z; Wen Z; Ying L
    J Tradit Chin Med; 2022 Oct; 42(5):795-802. PubMed ID: 36083488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased early activation of CD56dimCD16dim/- natural killer cells in immunological non-responders correlates with CD4+ T-cell recovery.
    Zhang QY; Zhang X; Su B; Liu LF; Yang XD; Tang B; Xia H; Ma P; Zhang T; Wu H
    Chin Med J (Engl); 2020 Nov; 133(24):2928-2939. PubMed ID: 33252378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders: a brief report.
    Xia H; Wang Y; Sun HL; Gao LY; Cao Y; Zaongo SD; Zeng RN; Wu H; Zhang MJ; Ma P
    Chin Med J (Engl); 2020 Dec; 133(23):2803-2807. PubMed ID: 33273328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive role of CD4
    Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
    BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression.
    Luo Z; Li Z; Martin L; Hu Z; Wu H; Wan Z; Kilby M; Heath SL; Huang L; Jiang W
    PLoS One; 2017; 12(1):e0167640. PubMed ID: 28076376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between CD4
    Lu D; Zhang JB; Wang YX; Geng ST; Zhang Z; Xu Y; Li SY; Wang KH; Kuang YQ
    BMC Infect Dis; 2021 Aug; 21(1):742. PubMed ID: 34344350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.
    Robbins GK; Spritzler JG; Chan ES; Asmuth DM; Gandhi RT; Rodriguez BA; Skowron G; Skolnik PR; Shafer RW; Pollard RB;
    Clin Infect Dis; 2009 Feb; 48(3):350-61. PubMed ID: 19123865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of TIM-3 expression on NK and T cell subsets in HIV immunological non-responders.
    de Kivit S; Lempsink LJ; Plants J; Martinson J; Keshavarzian A; Landay AL
    Clin Immunol; 2015 Jan; 156(1):28-35. PubMed ID: 25450337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An atlas of immune cell transcriptomes in human immunodeficiency virus-infected immunological non-responders identified marker genes that control viral replication.
    Chen Y; Li X; Liu S; Ao W; Lin J; Li Z; Wu S; Ye H; Han X; Li D
    Chin Med J (Engl); 2023 Nov; 136(22):2694-2705. PubMed ID: 37914674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort.
    Bayigga L; Nabatanzi R; Sekiziyivu PN; Mayanja-Kizza H; Kamya MR; Kambugu A; Olobo J; Kiragga A; Kirimunda S; Joloba M; Nakanjako D
    BMC Immunol; 2014 Jan; 15():2. PubMed ID: 24483185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of inhibitory and activating NK cell receptor expression on NK cells in HIV-infected Chinese.
    Jiang Y; He L; Chen H; Bice T; Zhang Z; Liu J; Ding H; Han X; Shang H
    Cell Immunol; 2011; 271(2):219-26. PubMed ID: 21813117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of integrated Traditional Chinese Medicine and anti-retroviral therapy on immunological nonresponse in patients with human immunodeficiency virus/acquired immunodeficiency syndrome: a Meta-analysis of randomized controlled trial.
    Tao Z; Huang XJ; Liu Y; Wang R; Dong JP; Liang BY; Zou W; Gao GJ; Wang Z; Zhang K; Wu H; Zhang T; Wang J
    J Tradit Chin Med; 2021 Oct; 41(5):669-676. PubMed ID: 34708624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of Mianyi granules (+mianyi+) for reversal of immune nonresponse following antiretroviral therapy of human immunodeficiency virus-1: a randomized, double-blind, multi-center, placebo-controlled trial.
    Ying L; Wen Z; Qingfei X; Xin D; Fuchun Z; Li W; Yonghong LI; Wenhui L; Jian W
    J Tradit Chin Med; 2022 Jun; 42(3):432-438. PubMed ID: 35610013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
    Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
    Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trial.
    Aladdin H; Ullum H; Dam Nielsen S; Espersen C; Mathiesen L; Katzenstein TL; Gerstoft J; Skinhoj P; Pedersen BK
    J Infect Dis; 2000 Mar; 181(3):1148-52. PubMed ID: 10720544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study.
    Cao W; Liu X; Han Y; Song X; Lu L; Li X; Lin L; Sun L; Liu A; Zhao H; Han N; Wei H; Cheng J; Zhu B; Wang M; Li Y; Ma P; Gao L; Wang X; Yu J; Zhu T; Routy JP; Zuo M; Li T
    Lancet Reg Health West Pac; 2023 May; 34():100724. PubMed ID: 37283977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The abnormal distribution of NK cell subsets before HAART treatment may be related to the level of immune reconstitution in HIV patient.
    Sun S; Kong W; Cui X; Lin Y; Lu B; Pan Y; Huang J; Hu X
    Int Immunopharmacol; 2021 Jul; 96():107784. PubMed ID: 34162148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological proliferation: a potential mechanism for poor CD4
    Zhang Y; Ji J; Xie K; Cai M; Wang R; Zhang X; Chen X; Zhang Y; Wu H; Wang W; Li Z; Zhang T
    Front Cell Infect Microbiol; 2024; 14():1344778. PubMed ID: 38601742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma MicroRNA Signature Panel Predicts the Immune Response After Antiretroviral Therapy in HIV-Infected Patients.
    Lv JN; Li JQ; Cui YB; Ren YY; Fu YJ; Jiang YJ; Shang H; Zhang ZN
    Front Immunol; 2021; 12():753044. PubMed ID: 34887859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.